Patents Examined by Dirk Bass
  • Patent number: 9809969
    Abstract: A system designed to control and filter runoff water in storm drains is presented. Drain water frequently carries trash, organic matter, suspended solids, hydrocarbons, metals, nutrients and bacteria collected from streets and parking lots into a storm drain inlet, which enters storm water drain pipe systems. The present invention supplies a series of baffle boxes inserted in the drain water stream with a final box possessing an upflow filter comprising filtration media and filter cartridges. The system can also support a storm flow bypass that directs high-flow storm runoff water directly to the outlet to protect the filter system.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: November 7, 2017
    Assignee: Bio Clean Environmental Services, Inc.
    Inventor: Zaccharia Kent
  • Patent number: 9802158
    Abstract: The present invention relates to ultrafiltration. In particular, the present invention provides nanoporous membranes having pores for generating in vitro and in vivo ultrafiltrate, devices and bioartificial organs utilizing such nanoporous membranes, and related methods (e.g., diagnostic methods, research methods, drug screening). The present invention further provides nanoporous membranes configured to avoid protein fouling with, for example, a polyethylene glycol surface coating.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: October 31, 2017
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, THE CLEVELAND CLINIC FOUNDATION
    Inventors: William H. Fissell, Shuvo Roy, Aaron Fleischman, Kenneth G. Goldman
  • Patent number: 9801901
    Abstract: The invention provides a method of overcoming resistance to at least one antibiotic in a multidrug resistant bacterium, said method comprising contacting said bacterium with an alginate oligomer together with the antibiotic. The multidrug resistant bacterium may be on an animate or inanimate surface and both medical and non-medical uses and methods are provided. In one aspect the invention provides an alginate oligomer for use together with at least one antibiotic in treating a subject infected, suspected to be infected, or at risk of infection, with a multidrug resistant bacterium to overcome resistance to the antibiotic in said multidrug resistant bacterium. In another aspect the method can be used to combat contamination of a site with multidrug resistant bacteria, e.g. for disinfection and cleaning purposes.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: October 31, 2017
    Assignee: ALGIPHARMA AS
    Inventors: Edvar Onsoyen, Rolf Myrvold, Arne Dessen, David Thomas, Timothy Rutland Walsh
  • Patent number: 9802841
    Abstract: Provided is a method for treating a hexavalent chromium-containing aqueous solution by water treatment employing a titanium dioxide photocatalyst that is excellent in both photocatalytic activity and solid-liquid separation performance. The method according to the present disclosure includes the steps of: adding catalyst particles to the aqueous solution; reducing hexavalent chromium by irradiating the aqueous solution with light having a wavelength of 200 nanometers or more and 400 nanometers or less while stirring the catalyst particles in the aqueous solution; and stopping the stirring and separating the catalyst particles from the aqueous solution by sedimentation. Each catalyst particle is composed only of a titanium dioxide particle and a zeolite particle, the titanium dioxide particle is adsorbed on the outer surface of the zeolite particle, the zeolite particle has a silica/alumina molar ratio of 10 or more, and the catalyst particles are contained in the aqueous solution at a concentration of 0.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: October 31, 2017
    Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Yuko Maruo, Daisuke Ino
  • Patent number: 9795697
    Abstract: Microfluidic systems including liquid containment regions and methods associated therewith for performing chemical, biological, or biochemical analyzes are provided. Liquid containment regions of a microfluidic device may include regions that capture one or more liquids flowing in the device, while allowing gases or other fluids in the device to pass through the region. This may be achieved, in some embodiments, by positioning one or more absorbent materials in the liquid containment region for absorbing the liquids. This configuration may be useful for removing air bubbles from a stream of fluid and/or for separating hydrophobic liquids from hydrophilic liquids. In certain embodiments, the liquid containment region prevents any liquid from passing through the region. In some such cases, the liquid containment region may act as a waste area by capturing substantially all of the liquid in the device, thereby preventing any liquid from exiting the device.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: October 24, 2017
    Assignee: OPKO Diagnostics, LLC
    Inventors: Vincent Linder, David Steinmiller, Jason Taylor
  • Patent number: 9782524
    Abstract: A surgical waste collection unit with a receiver for removably holding a manifold to which suction lines are connected. The receiver is mounted to the waste collection unit to be at an acute angle relative to the horizontal. The receiver is further configured to allow the manifold to be rotated in the receiver. This means the manifold can be rotated from a first position in which the manifold outlet opening is aligned with the conduit through which waste is flowed from the receiver and a second position in which the manifold outlet opening is elevated relative to the first position.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: October 10, 2017
    Assignee: STRYKER CORPORATION
    Inventors: Stephen Reasoner, David Hershberger, Brent S. Lalomia, Stephen Isham, Sean A. Murray
  • Patent number: 9783434
    Abstract: An immersed membrane system or process may use measured or calculated process information to optimize one or more process operating parameters to improve performance or reduce operating costs. An on-line process control system or method may use the resistance in series method in operating an immersed membrane water treatment system. A process control system or process may consider resistance values and adjust operational parameters such as membrane aeration frequency factor, membrane aeration flow, permeate flux, permeation duration, backwash flow and duration, relaxation duration or maintenance or recovery chemical cleaning frequencies in order to reduce the operational costs related to membrane fouling removal.
    Type: Grant
    Filed: August 23, 2010
    Date of Patent: October 10, 2017
    Assignee: ZENON TECHNOLOGY PARTNERSHIP
    Inventors: Boris Fernandes Ginzburg, Francois Yacoub, Pierre Lucien Cote, Arnold Janson
  • Patent number: 9786398
    Abstract: A nanocomposite solid material includes nanoparticles of a metal coordination polymer with CN ligands comprising Mn+ cations, in which M is a transition metal and n is 2 or 3; and anions [M?(CN)m]x? in which M? is a transition metal, x is 3 or 4, and m is 6 or 8. The Mn+ cations of the coordination polymer are bound through an organometallic bond to an organic group of an organic graft chemically attached inside the pores of a support made of porous glass. The material can be used in a method for fixing (binding) a mineral pollutant, such as radioactive cesium, contained in a solution by bringing the solution in contact with the nanocomposite solid material.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: October 10, 2017
    Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE MONTPELLER II
    Inventors: Agnes Grandjean, Yves Barre, Yannick Guari, Joulia Larionova, Christian Guerin
  • Patent number: 9777292
    Abstract: Described herein are processes for increasing biogas yield and reducing volatile solids in biosolids sludge. The biosolids sludge is passed through a controlled flow, hydrodynamic cavitation apparatus and further subjected to anaerobic digestion. The biosolids sludge can be treated with hydrodynamic cavitation prior to or after the sludge is exposed to a thermal hydrolysis step to hydrolyze the sludge.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: October 3, 2017
    Assignee: ARISDYNE SYSTEMS, INC.
    Inventors: Oleg Kozyuk, Peter Reimers
  • Patent number: 9770546
    Abstract: An apparatus is described for extracorporeal blood treatment (1), comprising a treatment unit (2), an extracorporeal blood circuit (8) and a fluid evacuation line (10). The apparatus comprises a control unit (21) connected with a pressure sensor (13, 14) and with a blood pump (9) and configured to move the blood pump (9), generating a variable flow (Q(t)) with a constant component (Qb) and a variable component (Qvar(t)) having a nil average value; the variable flow generates, in the expansion chamber (11, 12), a progression of the pressure that is variable over time (P(t)) with a pressure component (Pvar(t)) oscillating about an average value (Pavg).
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: September 26, 2017
    Assignee: Gambro Lundia AB
    Inventor: Alessandro Vasta
  • Patent number: 9772386
    Abstract: This disclosure relates to medical fluid sensors and related systems and methods. In certain aspects, a nuclear magnetic resonance device includes a support frame, a first magnet connected to the support frame, a second magnet connected to the support frame in a manner such that the second magnet is disposed within the magnetic field of the first magnet and a magnetic attraction exists between the first magnet and the second magnet, and a spacer disposed between the first magnet and the second magnet. The spacer is configured to maintain a space between the first magnet and the second magnet.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 26, 2017
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Ross Peter Jones, Simon Grover, Mark David Tuckwell
  • Patent number: 9764075
    Abstract: A membrane separation device is disclosed along with systems and methods employing the device in blood processing procedures. In one embodiment, a spinning membrane separator is provided in which at least two zones or regions are created in the gap between the membrane and the shell, such that mixing of the fluid between the two regions is inhibited by a radial rib associated with the membrane that decreases the gap between the membrane and the shell to define two fluid regions, the ridge isolating the fluid in the two regions to minimize mixing between the two. Automated systems and methods are disclosed for separating a unit of previously collected whole blood into components, such as concentrated red cells and plasma, for collecting red cells and plasma directly from a donor in a single pass, and for cell washing. Data management systems and methods and priming methods are also disclosed.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: September 19, 2017
    Assignee: Fenwal, Inc.
    Inventors: Bryan Blickhan, Kyungyoon Min, William H. Cork
  • Patent number: 9758387
    Abstract: A method for fluid treatment that provides variable or alternative regeneration cycles within the same fluid treatment device. The duration of all stages of the regeneration cycle can be adjusted depending upon the amount of fluid treated so that regenerant resources such as water are not underutilized and waste is not discharged unnecessarily into the environment. Additionally or alternatively, a regeneration sequence may include a fluid release sequence in which a fluid is released from a water treatment tank by successive linear movement of a piston in a valve assembly.
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: September 12, 2017
    Assignee: Water-Right, Inc.
    Inventors: Kurt Gruett, Guy Gruett, Gregory C. Gruett
  • Patent number: 9757503
    Abstract: A device and method for monitoring the connection of a blood treatment unit to a fluid system of an extracorporeal blood treatment apparatus are described, in which the blood treatment unit includes an inlet and an outlet for connection to the fluid system and the fluid system includes a line system with a first line segment connected to the inlet and a second line segment connected to the outlet. An extracorporeal blood treatment apparatus includes a device for monitoring the connection of the blood treatment unit to the fluid system. The device and method for monitoring the connection of the blood treatment unit to the fluid system is based on measurement of pressure in the fluid system of the blood treatment apparatus. Solely on the basis of the pressure measurement, it is ascertained whether the connection of the blood treatment unit to the fluid system is correct or incorrect.
    Type: Grant
    Filed: April 14, 2011
    Date of Patent: September 12, 2017
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Juergen Haecker, Soeren Gronau
  • Patent number: 9757504
    Abstract: Systems and methods for performing hemodialysis to remove metabolic waste from the blood of a patient are disclosed. The systems and methods preferably comprise at least one blood processing apparatus that receives whole blood from a patient. Cellular blood components are removed from the whole blood by hemofiltration, to provide filtered plasma comprising metabolic waste that is substantially reduced of blood cells. The cellular blood components may be returned to the patient. The filtered plasma comprising waste may be removed from the blood processing apparatus through a waste path for further processing in a separate apparatus, or in the same apparatus in a second stage processing procedure to remove metabolic waste components and excess water from the plasma by hemodialysis. At least one of the hemofiltration and hemodialysis processing apparatus comprises a Taylor vortex-enhanced separation apparatus.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: September 12, 2017
    Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SA
    Inventors: Randolph H. Watkins, Steven J. Wurgler, Shincy Maliekkal, Sujatha Karoor, Katrina Smith
  • Patent number: 9752730
    Abstract: A dialysis machine includes an ultrafiltration pump that pumps fluid from a pump inlet to a pump outlet, and a calibration fluid container. The container including a bottom, an upstanding sidewall, a container inlet and a container outlet, the bottom and the upstanding sidewall defining a container interior. The container may be to the atmosphere. At least the container outlet being disposed in the sidewall proximate to the bottom. The first end of a first hose is fluidly coupled to the pump inlet, and the second end of the first hose is removably, fluidly coupleable to the container outlet. The first end of a second hose is fluidly coupled to the pump outlet, and the second end of the second hose is removably, fluidly coupleable to the container inlet. In this way, a calibration process may be performed when the second ends of the first and second hoses are fluidly coupled to the container outlet and the container inlet, respectively.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: September 5, 2017
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventor: Phillip Voelz
  • Patent number: 9750864
    Abstract: The invention relates to a process for monitoring the supply of substitution fluid upstream or downstream of a dialyzer or filter arranged in an extracorporeal blood stream. One embodiment provides, for the detection of predilution or postdilution, for measuring the pressure in the blood stream downstream of the dialyzer or filter, predilution or postdilution being recognized on the basis of the change in pressure following the shutting off and/or starting up of the substituate pump provided for conveying the substitution fluid. Another embodiment provides for recognizing predilution or postdilution on the basis of the comparison of the oscillating pressure signal attributable to the substituate pump to a characteristic reference signal. The characteristic reference signal to which the pressure signal of the substituate pump is compared is preferably the oscillating pressure signal of a blood pump arranged in the blood stream for conveying the blood upstream of the dialyzer or filter.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: September 5, 2017
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventor: Pascal Kopperschimdt
  • Patent number: 9744284
    Abstract: A method for a hybrid blood and peritoneal dialysis (“PD”) machine comprising: (i) determining whether a previous treatment left a last fill of dialysate in a patient's peritoneum; (ii) if a next treatment is a PD treatment, and if the previous treatment did not leave the last fill of dialysate, causing a PD treatment in which a first cycle is a fill cycle to be initiated; (iii) if the next treatment is a PD treatment, and if the previous treatment did leave the last fill of dialysate, causing a PD treatment in which a first cycle is a last fill drain cycle to be initiated; and (iv) if the next treatment is a blood treatment and if the previous treatment did leave the last fill of dialysate, causing a blood treatment including a last fill drain cycle to be initiated.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: August 29, 2017
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Gino Cicchello, Christian Bernard, Robert W. Childers, Anthony Simiele
  • Patent number: 9744285
    Abstract: A machine is provided with a slot to releasably receive and retain a cartridge in which dialysis is effected. The machine is configured for supplying to the cartridge, at a controlled temperature and rate, sterile water for use in haemodialysis and is operable to maintain, in a sterile condition, residual water contained therein after completion of a haemodialysis treatment.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: August 29, 2017
    Assignee: Quanta Dialysis Technologies Limited
    Inventors: Keith James Heyes, Hugh Christopher Bramley, Alan Melvyn Bhimani
  • Patent number: 9725348
    Abstract: A method for providing an optimized organic load to a downstream wastewater treatment process includes the steps of: providing a primary wastewater treatment plant including an organic harvester (OH) with an OH effluent output stream with temporal variation in organic content, a sludge filtrate outflow from the primary wastewater treatment plant, a valve controlled by a controller, and a sensor communicatively coupled to the controller, the sensor disposed downstream of a combined outflow line to measure an organic content of a combined outflow to the downstream wastewater treatment process; sensing the organic content of the combined outflow to the downstream wastewater treatment process; adjusting the valve controlled by the controller to maintain about a setpoint organic content concentration of the combined outflow to the downstream wastewater treatment process by supplementing the OH effluent output stream with organically rich matter from the sludge filtrate outflow.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: August 8, 2017
    Assignee: ClearCove Systems, Inc.
    Inventor: Terry Wright